Fibrinopeptides A and B release in the process of surface fibrin formation

Blood

Volumn 117, Issue 5, 2011, Pages 1700-1705

  Riedel, Tomas ^a   Suttnar, Jiri ^a   Brynda, Eduard ^b   Houska, Milan ^b   Medved, Leonid ^c   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; THROMBIN;

ADSORPTION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA CHAIN; CONTROLLED STUDY; FIBRIN FORMATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION;

EID: 79551624917     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-300301     Document Type: Article

References (50)

1. Geer CB, Tripathy A, Schoenfisch MH, Lord ST, Gorkun OV. Role of B-b knob-hole interactions in fibrin binding to adsorbed fibrinogen. J Thromb Haemost. 2007;5(12):2344-2351. (Pubitemid 350154342)
2. Geer CB, Rus IA, Lord ST, Schoenfisch MH. Surface-dependent fibrinopeptide A accessibility to thrombin. Acta Biomater. 2007;3(5):663-668.
3. Evans-Nguyen KM, Fuierer RR, Fitchett BD, Tolles LR, Conboy JC, Schoenfisch MH. Changes in adsorbed fibrinogen upon conversion to fibrin. Langmuir. 2006;22(11):5115-5121.
4. Soman P, Rice Z, Siedliecki CA. Measuring the time-dependent functional activity of adsorbed fibrinogen by atomic force microscopy. Langmuir. 2008;24(16):8801-8806.
5. Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem. 1991;266(17):11227-11233.
6. Hu WJ, Eaton JW, Ugarova TP, Tang L. Molecular basis of biomaterial-mediated foreign body reaction. Blood. 2001;98(4):1231-1238.
7. Medved L, Weisel JW. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost. 2009;7(2):355-359.
8. Yang Z, Kollman JM, Pandi L, Doolittle RF. Crystal structure of native chicken fibrinogen at 2.7 angstrom resolution. Biochemistry. 2001;40(42):12515-12523. (Pubitemid 32979704)
9. Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF. Crystal structure of human fibrinogen. Biochemistry. 2009;48(18):3877-3886.
10. Lishko VK, Kudryk B, Yakubenko VP, Yee VC, Ugarova TP. Regulated unmasking of the cryptic binding site for integrin alpha(M)beta(2) in the gamma C-domain of fibrinogen. Biochemistry. 2002;41(43):12942-12951.
11. Medved L, Nieuwenhuizen W. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost. 2003;89(3):409-419. (Pubitemid 36329229)
12. Blombäck B. Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis. Thromb Res. 1996;83(1):1-75. (Pubitemid 26274439)
13. Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A. 2000;97(26):14156-14161. (Pubitemid 32016546)
14. Weisel JW. Fibrin assembly-lateral aggregation and the role of the 2 pairs of fibrinopeptides. Biophys J. 1986;50(6):1079-1093.
15. Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol. 1993;232(1):285-297.
16. Blombäck B, Hessel B, Hogg D, Therkildsen L. 2-step fibrinogen-fibrin transition in blood coagulation. Nature. 1978;275(5680):501- 505.
17. Fredenburgh JC, Stafford AR, Pospisil CH, Weitz JI. Modes and consequences of thrombin's interaction with fibrin. Biophys Chem. 2004;112(2-3):277-284.
18. Di Cera E. Thrombin interaction. Chest. 2003; 124(3):11S-17S.
19. Binnie CG, Lord ST. The fibrinogen sequences that interact with thrombin. Blood. 1993;81(12):3186-3192.
20. Pechik I, Madrazo J, Mosesson MW, Hernandez I, Gilliland GL, Medved L. Crystal structure of the complex between thrombin and the central 'E' region of fibrin. Prox Natl Acad Sci U S A. 2004;101(9):2718-2723.
21. Mullin JL, Gorkun OV, Binnie CG, Lord ST. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release. J Biol Chem. 2000;275(33):25239-25246.
22. Pechik I, Yakovlev S, Mosesson MW, Gilliland GL, Medved L. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry. 2006;45(11):3588-3597.
23. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-299.
24. Blombäck B, Bark N. Fibrinopeptides and fibrin gel structure. Biophys Chem. 2004;112(2-3):147-151.
25. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178(6):2147-2156. (Pubitemid 23344872)
26. Laurens N, Koowijk P, De Maat MPM. Fibrin structure and wound healing. J Thromb Haemost. 2006;4(5):932-939.
27. Dyr JE, Tichý I, Jirousková M, et al. Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor. Sens Actuators B Chem. 1998;51(1-3):268-272.
28. Dyr JE, Cajthamlova H, Suttnar J, Fortova H. Fibrinopeptide release from surface-bound fibrinogen. In: Ernst E., Koenig W, Low GDO, Meade TW, eds. Fibrinogen: a 'new' cardiovascular risk factor. Vienna: Blackwell-MZV; 1992. p. 27-30.
29. Brynda E, Houska M, Lednicky F. Adsorption of human fibrinogen onto hydrophobic surfaces: The effect of concentration in solution. J Colloid Interface Sci. 1986;113(1):164-171.
30. Jirousková M, Dyr JE, Suttnar J, Holada K, Trnková B. Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood - the effect of fibrinogen immobilization and fibrin formation. Thromb Haemost. 1997;78(3):1125-1131. (Pubitemid 27417312)
31. Dyr JE, Jirousková M, Rysavá J, et al. Surface plasmon resonance analysis of immobilized fibrinogen and fibrin and their interaction with thrombin and fibrinogen. In: Baldini F, Croitoru NI, Frenz M, et al, eds. Proceedings of the Society of Photo-Optical Instrumentation Engineers. Bellingham, WA: SPIE; 1999. p. 176-183.
32. Weisel JW. The electron microscope band pattern of human fibrin: Various stains, lateral order, and carbohydrate localization. J Ultrastruct Mol Struct Res. 1986;96(1-3):176-188.
33. Riedel T, Brynda E, Dyr JE, Houska M. Controlled preparation of thin fibrin films immobilized at solid surfaces. J Biomed Mater Res A. 2009;88(2):437-447.
34. Suttnar J, Dyr JE, Fortová H, Pristach J. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov. 1989;18:17-25.
35. Doolittle RF. X-ray crystallographic studies on fibrinogen and fibrin. J Thromb Haemost. 2003;1(7):1559-1565.
36. Chtcheglova LA, Vogel M, Gruber HJ, Dietler G, Haeberli A, Kinetics of the interaction of desAABBFibrin monomer with immobilized fibrinogen. Biopolymers. 2006;83(1):69-82.
37. Dyr JE, Blombäck B, Hessel B, Kornalík F. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. Biochim Biophys Acta. 1989;990(1):18-24.
38. Evans-Nguyen KM, Tolles LR, Gorkun OV, Lord ST, Schoenfisch MH. Interaction of thrombin with fibrinogen adsorbed on methyl-, hydroxyl-, amine-, and carboxyl-terminated self-assembled monolayers. Biochemistry. 2005;44(47):15561-15568.
39. Petzelbauer P, Zacharowski PA, Miyazaki Y, et al. The fibrin-derived peptide B beta(15-42) protects the myocardium against ischemia-reperfusion injury. Nat Med. 2005;11(3):298-304.
40. Zacharowski K, Zacharowski P, Reingruber S, Petzelbauer P. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med. 2006;84(6):469-477.
41. Kay AB, Pepper DS, McKenzie R. The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen. Br J Haematol. 1974;27(4):669-677.
42. Skogen WF, Senior RM, Griffin GL, Wilner GD. Fibrinogen-derived peptide B beta 1-42 is a multidomain neutrophil chemoattractant. Blood. 1988;71(5):1475-1479.
43. Erban JK, Wagner DD. A 130-kDa protein on endothelial cells binds to amino acids 15-42 of the B beta chain of fibrinogen. J Biol Chem. 1992; 267(4):2451-2458.
44. Martinez J, Ferber A, Bach TL, Yaen CH. Interaction of fibrin with VE-cadherin. Ann N Y Acad Sci. 2001;936:386-405.
45. Weitz JI, Koehn JA, Canfield RE, Landman SL, Friedman R. Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42. Blood. 1986;67(4):1014-1022.
46. Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96(10):3302-3309.
47. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood. 1995;86(5):1802-1810.
48. Sturge J, Carey N, Davies AH, Powell JT. Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein. J Vasc Surg. 2001;33(4):847-853.
49. Lishko VK, Burke T, Tatiana Ugarova T. Antiadhesive effect of fibrinogen: a safeguard for thrombus stability. Blood. 2007;109(4):1541-1549. (Pubitemid 46239587)
50. Podolnikova NP, Yermolenko IS, Fuhrmann A, et al. Control of integrin RIIbβ3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates. Biochemistry. 2010;49(1):68-77.